Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Fate Therapeutics, Inc. (FATE)

« Back to company index

FATE Chatter Timeline

Stock Ticker for FATE

Most Active Tweeters for FATE

UserTweets
@Gambiste1 14
@Tickeron 12
@MDegn67 8
@EnterpriseLeade 6
@ThisLincolnian 6

Recent Tweets for FATE

Tickeron @Tickeron
$FATE in Uptrend: price may jump up because it broke its lower Bollinger Band on March 16, 2020. View odds for this… https://t.co/njF1x99xUx
April 9th 2020, 4:04pm
bbnsnews @bbnsnews
Oppenheimer Cuts Fate Therapeutics $FATE Price Target to $34.00 https://t.co/GHdfOE1L3g
April 9th 2020, 1:04pm
WeekHerald @WeekHerald
Oppenheimer Cuts Fate Therapeutics $FATE Price Target to $34.00 https://t.co/Qc1Ca771Zw
April 9th 2020, 12:04pm
b_ownthenight @b_ownthenight
$FATE Getting bought up today!
April 9th 2020, 12:04pm
ThisLincolnian @ThisLincolnian
Q2 2020 Earnings Forecast for Fate Therapeutics Inc $FATE Issued By Oppenheimer https://t.co/78nwJVBAGD
April 9th 2020, 2:04am
TickerReport @TickerReport
Q2 2020 Earnings Forecast for Fate Therapeutics Inc $FATE Issued By Oppenheimer https://t.co/5iAtF8RY3l
April 9th 2020, 2:04am
gcassidy718 @gcassidy718
$FATE this is the time you buy equities thank you fed 3.10 % change recently https://t.co/rJRHk0DOAl
April 8th 2020, 3:04pm
Tickeron @Tickeron
$FATE's Aroon indicator drops into Downtrend on March 6, 2020. View odds for this and other indicators:… https://t.co/WFwoKIsrKK
April 8th 2020, 12:04pm
dakotafinancial @dakotafinancial
Oppenheimer Weighs in on Fate Therapeutics Inc’s Q2 2020 Earnings $FATE https://t.co/bEB3trc4Vm
April 8th 2020, 8:04am
dhovekamp42 @dhovekamp42
RT @AmericanBanking: Oppenheimer Weighs in on Fate Therapeutics Inc’s Q2 2020 Earnings $FATE https://t.co/YMBpG4zR6y #stocks
April 8th 2020, 8:04am
AmericanBanking @AmericanBanking
Oppenheimer Weighs in on Fate Therapeutics Inc’s Q2 2020 Earnings $FATE https://t.co/YMBpG4zR6y #stocks
April 8th 2020, 8:04am
TranscriptDaily @TranscriptDaily
Oppenheimer Weighs in on Fate Therapeutics Inc’s Q2 2020 Earnings $FATE https://t.co/TU3GzyXWgL
April 8th 2020, 8:04am
ConsumerFeed @ConsumerFeed
Oppenheimer Brokers Increase Earnings Estimates for Fate Therapeutics Inc $FATE https://t.co/q4NEsCRUvq
April 8th 2020, 8:04am
TickerReport @TickerReport
Fate Therapeutics $FATE PT Lowered to $34.00 https://t.co/exUrEO6SwR
April 8th 2020, 4:04am
ZolmaxNews @ZolmaxNews
Fate Therapeutics Inc $FATE Receives Average Rating of “Buy” from Analysts https://t.co/DMdrfrnYKj
April 8th 2020, 2:04am
ThisLincolnian @ThisLincolnian
Fate Therapeutics Inc $FATE Receives Average Rating of “Buy” from Analysts https://t.co/HVxOZy7jI8
April 8th 2020, 2:04am
AmericanBanking @AmericanBanking
Fate Therapeutics Inc $FATE Receives Average Rating of “Buy” from Analysts https://t.co/yliULep1L0 #stocks
April 8th 2020, 1:04am
WatchlistN @WatchlistN
Fate Therapeutics Inc $FATE Receives Consensus Rating of “Buy” from Brokerages https://t.co/MucSelyZPO
April 8th 2020, 1:04am
TickerReport @TickerReport
Fate Therapeutics Inc $FATE Receives Average Rating of “Buy” from Analysts https://t.co/0ThvnJvcZf
April 8th 2020, 1:04am
dakotafinancial @dakotafinancial
Fate Therapeutics $FATE Shares Up 6.9% on Analyst Upgrade https://t.co/iKdjwxGbBV
April 8th 2020, 1:04am
ConsumerFeed @ConsumerFeed
Fate Therapeutics $FATE Trading Up 6.9% Following Analyst Upgrade https://t.co/vT1OluE892
April 8th 2020, 1:04am
ThisLincolnian @ThisLincolnian
Fate Therapeutics $FATE Shares Up 6.9% on Analyst Upgrade https://t.co/YcAATdRVbV
April 8th 2020, 1:04am
Dadbod4evah @Dadbod4evah
@dhovekamp42 @nresearchnews This is what $fate is exploring...you should hear more about it within the coming month… https://t.co/O5zkV2NXsy
April 7th 2020, 8:04pm
HealthcareBeat @HealthcareBeat
Fate Therapeutics Price Target Cut to $34.00 $FATE https://t.co/T6p8fVpG5P
April 7th 2020, 1:04pm
Tickeron @Tickeron
$FATE's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/eVHBdHs0vH
April 7th 2020, 1:04pm
Gambiste1 @Gambiste1
RT @PersimmonTI: $FATE Fate continues to be a good buy, here, imho. /conviction.
April 7th 2020, 12:04pm
PersimmonTI @PersimmonTI
$FATE Fate continues to be a good buy, here, imho. /conviction.
April 7th 2020, 12:04pm
8thKingofRome @8thKingofRome
@LeeSwan88663553 Why not? $FATE used to as well. And many others bio then partnered or acquired. It is… https://t.co/j9QAIkt8dD
April 7th 2020, 11:04am
Gambiste1 @Gambiste1
RT @ChartMill: $FATE was analyzed by 16. The buy percentage consensus is at 95. So analysts seem to be very confident about $FATE. https://…
April 7th 2020, 7:04am
WatchlistN @WatchlistN
Fate Therapeutics $FATE Price Target Increased to $41.00 by Analysts at Wedbush https://t.co/rd9EhHTIqg
April 7th 2020, 6:04am
ChartMill @ChartMill
$FATE was analyzed by 16. The buy percentage consensus is at 95. So analysts seem to be very confident about $FATE.… https://t.co/yN4UkMcsgd
April 7th 2020, 5:04am
HealthcareBeat @HealthcareBeat
Mizuho Reaffirms Buy Rating for Fate Therapeutics $FATE https://t.co/F8xV3GDKWg
April 7th 2020, 4:04am
stocknewstimes @stocknewstimes
Mizuho Reaffirms Buy Rating for Fate Therapeutics $FATE https://t.co/HeSBoqcDIV
April 7th 2020, 4:04am
dispatchtribune @dispatchtribune
Mizuho Reaffirms Buy Rating for Fate Therapeutics $FATE https://t.co/clufotCisP
April 7th 2020, 4:04am
TickerReport @TickerReport
Fate Therapeutics $FATE Stock Price Up 6.9% on Analyst Upgrade https://t.co/tEE5oddV0X
April 7th 2020, 1:04am
ZolmaxNews @ZolmaxNews
Fate Therapeutics $FATE Shares Up 6.9% After Analyst Upgrade https://t.co/7N0RB7MzCw
April 7th 2020, 1:04am
Jon12508683 @Jon12508683
looking to add $fate if dips. long term hold.
April 6th 2020, 6:04pm
Gambiste1 @Gambiste1
RT @MonacoTrader: Today's trades. Overall a great day. All discussed in realtime at https://t.co/vxzjHJVP3A (now FREE to everyone). $FATE…
April 6th 2020, 3:04pm
stocknewstimes @stocknewstimes
Fate Therapeutics $FATE Trading 6.9% Higher After Analyst Upgrade https://t.co/tvPsYsGfcn
April 6th 2020, 2:04pm
HealthcareBeat @HealthcareBeat
Fate Therapeutics Trading 6.9% Higher After Analyst Upgrade $FATE https://t.co/V2DhQ0ZyCx
April 6th 2020, 2:04pm
dispatchtribune @dispatchtribune
Fate Therapeutics $FATE Trading 6.9% Higher Following Analyst Upgrade https://t.co/HorGIgRbCL
April 6th 2020, 2:04pm
TranscriptDaily @TranscriptDaily
Fate Therapeutics $FATE Trading 6.9% Higher Following Analyst Upgrade https://t.co/C4sUSUnrrH
April 6th 2020, 2:04pm
_RobTrader_ @_RobTrader_
$FATE squeezing https://t.co/SeY2LoCZdY
April 6th 2020, 2:04pm
MDegn67 @MDegn67
$FATE "Scott Wolchko on Q4 Conference Call about partnering "We think we have the potential to partner up with comp… https://t.co/yBccp0ounY
April 6th 2020, 1:04pm
Tickeron @Tickeron
$FATE in Uptrend: price may jump up because it broke its lower Bollinger Band on March 16, 2020. View odds for this… https://t.co/F8tEwvNN1H
April 6th 2020, 12:04pm
AmericanBanking @AmericanBanking
Fate Therapeutics $FATE PT Lowered to $34.00 https://t.co/NkohdZYfHu #stocks
April 6th 2020, 12:04pm
dispatchtribune @dispatchtribune
Wedbush Boosts Fate Therapeutics $FATE Price Target to $41.00 https://t.co/h0hIkOD5Qt
April 6th 2020, 12:04pm
EnterpriseLeade @EnterpriseLeade
Wedbush Boosts Fate Therapeutics $FATE Price Target to $41.00 https://t.co/Amed7AptuR
April 6th 2020, 12:04pm
dakotafinancial @dakotafinancial
Fate Therapeutics $FATE Price Target Cut to $34.00 by Analysts at Oppenheimer https://t.co/g5iI3b935S
April 6th 2020, 11:04am
EnterpriseLeade @EnterpriseLeade
Fate Therapeutics $FATE PT Lowered to $34.00 at Oppenheimer https://t.co/cO2Sa9N9ty
April 6th 2020, 11:04am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.